STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Oncological Nursing and Practices Review Article

Nurse’s Responsibility and Liability in Chemotherapy Formulation: Legal and Ethical Considerations

  1. Rupinder Kaur Department of Oncology Nursing, Sri Guru Ram Das University of Health Sciences

Abstract

Each year, over 16 million new cancer cases are diagnosed globally. Cancer causes cells to grow uncontrollably, potentially leading to the formation of tumors, immune system damage, and other debilitating effects that can be fatal. Common cancer treatments include surgery to remove tumors, chemotherapy, radiation therapy, hormonal therapy, and immunotherapy. Among these, chemotherapy plays a significant role, accounting for nearly half of the overall treatment approach. Chemotherapy drugs can be administered through various methods, but they are often nonselective, affecting both cancerous and healthy cells in numerous organs and tissues. While chemotherapy can be lifesaving for patients, the preparation and administration of these drugs come with significant risks, including teratogenic, mutagenic, and carcinogenic effects for both patients and healthcare workers. Therefore, it is essential that only nurses with specialized training in chemotherapy preparation be entrusted with these responsibilities. Ensuring the safety of both patients and healthcare providers is a key priority throughout the entire chemotherapy treatment process. Additionally, healthcare workers must be well-versed in proper procedures for cleaning chemotherapy spills. Beyond the patient’s well-being, the occupational health risks to healthcare workers handling these potent drugs must also be fully addressed to minimize exposure and ensure a safe working environment.

Keywords

References (10)

  1. Mayo Clinic. Chemotherapy. [Online]. Available at: https://www.mayoclinic.org/tests-procedures/ chemotherapy/about/pac-20385033
  2. Celano P, Fausel CA, Kennedy EB, Miller TM, Oliver TK, Page R, et al. Safe Handling of Hazardous Drugs: ASCO Standards. Journal of Clinical Oncology. 2019;37(7):598-609. doi:10.1200/jco.18.01616
  3. Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J Clin. 2006; 56(6): 354–65.
  4. Centers for Disease Control and Prevention. NIOSH (National Institute for Occupational Safety and Health). 2004. NIOSH alert: preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. DHHS (NIOSH) Publication No. 2004-165. [Online]. Available at: https://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf
  5. Power LA, Coyne JW. ASHP Guidelines on Handling Hazardous Drugs. American Journal of Health-System Pharmacy. 2018;75(24):1996-2031. doi:10.2146/ajhp180564
  6. International Society of Oncology Pharmacy Practitioners Standards Committee. ISOPP standards of practice. Safe handling of cytotoxics. J Oncol Pharm Pract. 2007; 13Suppl: 1– doi:10.1177/1078155207082350. PMID: 17933809.
  7. Polovich M, editor. Safe handling of hazardous drugs. 3rd Edn. Pittsburgh: Oncology Nursing Society; 2011. Available online at: https://www.ons.org/sites/default/files/2018-10/Safe%20 Handling%20of%20Hazardous%20Drugs%20Third%20Edition%20Sample%20Chapter_0.pdf
  8. Perez Fidalgo JA, et al. Management of chemotherapy extravasation: ESMO–EONS Clinical Practice Guidelines. AnnOncol. 2012 Oct; 23(Suppl 7): vii167–vii173.
  9. Salim NAS, Mrayyan MT. Chemotherapy Spills Management Policy. Middle East Journal of Nursing. 2014;8(4):19-25. doi:10.5742/mejn.2014.92589
  10. Eisenberg S. What are your concerns regarding safe handling of chemotherapy? ONS Connect. 2008 Aug; 23(8): PMID: 18767568.